BlackRock »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by BlackRock

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by BlackRock

Quarter filed Position value Share count Share price at filing
2024-06-30 $39M 35M 1.11
2024-03-31 $5.3M 5.5M 0.97
2023-09-30 $11M 12M 0.93

More positions owned by BlackRock

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Broadcom (AVGO)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)
Tesla Motors (TSLA)
UnitedHealth (UNH)
Ishares Tr Core S&p500 Etf (IVV)
Exxon Mobil Corporation (XOM)

View all positions for BlackRock

Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1

M&G
Calamos Advisors
Wolverine Asset Management
MacKay Shields
Lazard Asset Management
Millennium Management
BlackRock
Camden Asset Management
Advent Capital Management
Polar Securities
Bank of America Corporation
Magnetar Financial
State Street Corporation
CNH Partners
Citadel Advisors

View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1